Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick

The article compares Eli Lilly and Company and Novo Nordisk A/S in the GLP-1 market. Click to know why LLY leads over NVO and how Novo may rebound.

CryptoAlerta — análise de criptomoedas e mercado em tempo real